Physician profile
Jeronimo Guzman
NPI 1336347012
$6,014.89
in general payments reported to CMS, 2019-2025
9 companies · $836 in 2025
The $836 reported for 2025 was more than what 84% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $13.06 · 2021: $243 · 2022: $506 · 2023: $817 · 2024: $3,172 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694 · Travel and Lodging: $2,034 · Gift: $96.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.32 |
| Travel and Lodging | $2,034.42 |
| Gift | $96.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,286.84 | 2024 | Na |
| Zimvie INC. | $2,169.84 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $601.75 | 2019-2021 | |
| Straumann USA LLC | $477.13 | 2023-2025 | |
| Biohorizons Implant Systems INC. | $207.08 | 2022-2025 | Biohorizons Dental Implants, Biohorizons |
| Pacira Pharmaceuticals Incorporated | $113.40 | 2023 | Exparel |
| Neoss, INC. | $76.61 | 2022 | |
| Nobel Biocare USA | $50.00 | 2021 | |
| Dentsply Ih INC. | $32.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeronimo Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.